Intrathecal synthesis of interferon in the absence of viral or bacterial infection was detected during the occurrence of neurological complications in two patients with systemic lupus erythematosus. The interferons displayed characteristics similar to those observed in the sera of patients with the disease. No interferon inducing activity was detected in the cerebrospinal fluid or serum of the two patients.
Introduction oc Interferon is produced by non-T' and non-B2 3 lymphocytes and monocytes. In man these cells may be induced by infectious or inactivated viruses4 5 or after contact with virus infected and glutaraldehyde fixed cells.6 In some tissues for example, embryonic fibroblasts and amniotic membranes-ca interferon may be synthesised simultaneously with P interferon.7 8
Recent studies show that during the acute phase of systemic lupus erythematosus high levels of an a interferon (pH 2 labile) may be detected in the sera of more than 70% of patients. 9 -13 The role of interferon and the induction mechanism in this disease are unknown. Leucocytes from patients secreting interferon do not release a interferon spontaneously in vitro'4 but can be induced for the synthesis of y interferon." These findings suggest that the x interferon detected in the serum of these patients may be produced by tissue bound lymphocytes rather than by circulating cells. We confirm and extend this hypothesis by describing the synthesis of interferon localised in the central nervous system of two patients with systemic lupus erythematosus.
Patients and methods
Case 1-A 7 year old girl with a two month history of systemic lupus erythematosus, developed seizures of the right side and coma for four weeks, associated with fever, facies erythematosus, and conjunctivitis. No Serum and cerebrospinal fluid antibodies were tested by microassays, cytopathic effect neutralisation, complement fixation, and haemagglutination inhibition. Measles, rubella, and mumps IgM antibodies were sought by haemagglutination inhibition after separation from the sera by ultracentrifugation on sucrose gradients.
Interferon was assayed on bovine cells sensitive to a interferon (MDBK) and challenged with vesicular stomatitis virus, as described.'
Interferon antibodies were tested in sera and cerebrospinal fluid collected during convalescence: 100 Hl sera (diluted 1/4) and cerebrospinal fluid (diluted 1/2) were added to 100 IU interferon (100 41).
The mixture was incubated for one hour at 37°C and for the next hour at 4°C and the residual activity of interferon titrated in MDBK cells.
Serum and cerebrospinal fluid interferons were also titrated after dialysis for 24 hours with two changes of 0 1 M glycine buffer adjusted to pH 2. They were then typed with sheep anti-a interferon (Dr C Chany), rabbit anti-: interferon (Dr J Vilcek), and anti-y interferon (J Johnson, J Stanton) sera.
Serum and cerebrospinal fluid containing interferon were tested for their ability to induce a interferon in lymphocytes from healthy donors: 100 tdl samples were incubated with 1 ml lymphocytes (106 cells/ml) at 37zC for one to five days. Sendai virus (E72 strain) and herpesvirus (type I) were used as controls. The supernatants were tested for the presence of interferon by assay using MDBK cells before and after pH 2 treatment.
Results
Neither virus nor bacteria were detected in the cerebrospinal fluid samples. Serological tests did not show a rise of antibody titre in either of two sera from each patient or in cerebrospinal fluid against mycoplasma and the following common neuropathogenic viruses: herpes, varicella, mumps, measles, Epstein-Barr, cytomegalovirus, Coxsackie B, influenzae A and B, adenovirus, and respiratory syncytial virus. Measles, rubella, and mumps IgM antibodies were not detected in the sera. Large amounts of interferon, however, were detected in the first cerebrospinal fluid sample from these two patients. The In case 1 interferon was also present in the serum but at a lesser concentration. In case 2 interferon was not detected in serum taken four days after the collection of cerebrospinal fluid. The antiviral activity of this interferon was neutralised by anti-cL but not by anti-5 or anti-y interferon sera. It was partially inhibited by pH 2 treatment (data not shown). No anti-cx interferon activity was detected in serum or cerebrospinal fluid taken at two weeks (case 1) or two months (case 2) in the course of the disease.
The first cerebrospinal fluid and serum samples collected from both patients had no interferon inducing activity after contact with lymphocytes of healthy donors.
Discussion
The presence of high concentrations of interferon in the cerebrospinal fluid of children with acute encephalopathies is a rare phenomenon (only 10% of cases; P Lebon, unpublished), generally not observed in postinfectious encephalitis but associated only with primary encephalitis (K Hamano et al, submitted for publication).'5,-" None of the most important neuropathogenic viruses could be implicated in the neurological complications of the two children in our study despite the presence of intrathecal interferon. In both cases cerebrospinal fluid a interferon was slightly inactivated when treated at pH 2 and differed in this respect from the variant detected in herpes encephalitis. It was, however, neutralised by serum containing anti-cx interferon but not by serum containing anti-5 or anti-y interferon. These characteristics are similar to those of interferons reported in the serum in systemic lupus erythematosus."1 In our two cases interferon was predominantly synthesised in the central nervous system, the intrathecal values being higher than those in the serum. Direct production of a interferon by cells of the central nervous system other than leucocytes due to an infectious virus was not likely since it was not associated with synthesis of 3 interferon. Probably also induction could not be attributed to an intrathecal soluble antigen, since spinal fluids themselves tapped at the onset of the neurological symptoms did not induce any interferon in lymphocytes from healthy donors (data not shown).
The intrathecal synthesis of a interferon in these patients may be attributed to the expression of new antigens in the membrane of local cells. These might induce interferon after contact with the membrane of lymphocytes. Such a mechanism of induction has been shown in vitro: indeed, human a interferon may be induced after interaction of blood mononuclear cells with transformed cells"9 or with glutaraldehyde fixed herpesvirus infected cells, but not with uninfected fibroblasts.5 A similar process of induction has also been observed in vivo: at the onset of herpes encephalitis intrathecal interferon almost invariably present in the cerebrospinal fluid'6 "8 was induced by viral antigens bound to the nervous tissue. Indeed, soluble viral antigens are rarely detected in the spinal fluid by radioimmunoassay or enzyme immunoassay.
These observations confirm that the interferon in the course of systemic lupus erythematosus is produced by organ bound lymphocytes, as suggested.'" If such an induction mechanism as the one proposed here occurs in this disease, a interferon and especially the pH 2 sensitive variant could be used in vitro as a marker to detect foreign antigens or biochemical modifications in the cell membrane of damaged tissues.
It is now well documented that interferons increase the severity of autoimmune disease in NZB mice.2'-22 Some pathological changes characteristic of systemic lupus erythematosus might also be related to the presence of interferons in serum and cerebrospinal fluid. Thus the favourable outcome in both of our cases after intravenous administration of corticosteroids might have been attributable to the suppressive effect of these drugs on the production of a interferon.
